TY  - GEN
AU  - Uckun,F M
AU  - Chelstrom,L M
AU  - Finnegan,D
AU  - Tuel-Ahlgren,L
AU  - Manivel,C
AU  - Irvin,J D
AU  - Myers,D E
AU  - Gunther,R
TI  - Effective immunochemotherapy of CALLA+C mu+ human pre-B acute lymphoblastic leukemia in mice with severe combined immunodeficiency using B43 (anti-CD19) pokeweed antiviral protein immunotoxin plus cyclophosphamide
SN  - 0006-4971
PY  - 1992///0709
KW  - Animals
KW  - Antibodies, Monoclonal
KW  - therapeutic use
KW  - Antigens, CD
KW  - immunology
KW  - Antigens, CD19
KW  - Antigens, Differentiation, B-Lymphocyte
KW  - Antineoplastic Agents, Phytogenic
KW  - administration & dosage
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Base Sequence
KW  - Chromosome Aberrations
KW  - Cyclophosphamide
KW  - DNA, Neoplasm
KW  - chemistry
KW  - Humans
KW  - Immunoglobulin mu-Chains
KW  - analysis
KW  - Immunophenotyping
KW  - Immunotoxins
KW  - Mice
KW  - Mice, SCID
KW  - Molecular Sequence Data
KW  - N-Glycosyl Hydrolases
KW  - Neoplasm Transplantation
KW  - Plant Proteins
KW  - Polymerase Chain Reaction
KW  - Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
KW  - drug therapy
KW  - Ribosome Inactivating Proteins, Type 1
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S
ER  -